These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 36409765)

  • 21. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis.
    Lu Y; Cui A; Zhang X
    Gut Microbes; 2024; 16(1):2348441. PubMed ID: 38706224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.
    Wang X; Undi RB; Ali N; Huycke MM
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 33969420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harness the functions of gut microbiome in tumorigenesis for cancer treatment.
    Lee MH
    Cancer Commun (Lond); 2021 Oct; 41(10):937-967. PubMed ID: 34355542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer.
    Privitera G; Rana N; Scaldaferri F; Armuzzi A; Pizarro TT
    Front Cell Infect Microbiol; 2021; 11():806680. PubMed ID: 35111698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.
    Yixia Y; Sripetchwandee J; Chattipakorn N; Chattipakorn SC
    Anaerobe; 2021 Apr; 68():102361. PubMed ID: 33781900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention.
    Lee SY; Lee DY; Kang JH; Kim JH; Jeong JW; Kim HW; Oh DH; Yoon SH; Hur SJ
    Food Res Int; 2022 Jun; 156():111327. PubMed ID: 35651078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Role of Gut Microbiome in Colon Cancer.
    Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut mucosal microbiome across stages of colorectal carcinogenesis.
    Nakatsu G; Li X; Zhou H; Sheng J; Wong SH; Wu WK; Ng SC; Tsoi H; Dong Y; Zhang N; He Y; Kang Q; Cao L; Wang K; Zhang J; Liang Q; Yu J; Sung JJ
    Nat Commun; 2015 Oct; 6():8727. PubMed ID: 26515465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Western lifestyle as a driver of dysbiosis in colorectal cancer.
    Foegeding NJ; Jones ZS; Byndloss MX
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34060626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis.
    Cheng KW; Tseng CH; Chen IJ; Huang BC; Liu HJ; Ho KW; Lin WW; Chuang CH; Huang MY; Leu YL; Roffler SR; Wang JY; Chen YL; Cheng TL
    Pharmacol Res; 2022 Mar; 177():106115. PubMed ID: 35124207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.